Total Payments
$6,608
2024 Payments
$1,647
Companies
36
Transactions
421
Medicare Patients
1,245
Medicare Billing
$429,606
Payment Breakdown by Category
Food & Beverage$6,608 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,608 | 421 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,337 | 85 | $0 (2024) |
| ABBVIE INC. | $1,309 | 103 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $472.23 | 29 | $0 (2024) |
| Lilly USA, LLC | $444.62 | 32 | $0 (2024) |
| PFIZER INC. | $413.82 | 27 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $276.96 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $224.08 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $215.19 | 13 | $0 (2022) |
| Abbott Laboratories | $214.02 | 10 | $0 (2024) |
| Amarin Pharma Inc. | $189.68 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,647 | 95 | ABBVIE INC. ($344.96) |
| 2023 | $1,745 | 117 | ABBVIE INC. ($429.32) |
| 2022 | $1,956 | 126 | Novo Nordisk Inc ($421.84) |
| 2021 | $1,260 | 83 | AbbVie Inc. ($285.85) |
All Payment Transactions
421 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.58 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Neurology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Diabetes Care | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: VACCINE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: PAIN | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Oncology | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Obesity | ||||||
| 08/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: DIABETES | ||||||
| 08/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 475 | 2,802 | $176,806 | $64,559 |
| 2022 | 10 | 368 | 1,309 | $108,260 | $36,890 |
| 2021 | 10 | 402 | 17,090 | $1.2M | $328,157 |
Total Patients
1,245
Total Services
21,201
Medicare Billing
$429,606
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 32 | 2,100 | $68,373 | $36,010 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 216 | $49,680 | $15,853 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 85 | $13,005 | $4,208 | 32.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 50 | 93 | $17,949 | $3,641 | 20.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $4,976 | $1,863 | 37.4% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 25 | 94 | $5,546 | $1,216 | 21.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 71 | 92 | $2,300 | $772.80 | 33.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 43 | 68 | $12,920 | $597.30 | 4.6% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 14 | 15 | $1,620 | $347.55 | 21.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 23 | $437.00 | $50.60 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 212 | $48,760 | $15,485 | 31.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 13 | 780 | $26,816 | $13,693 | 51.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 23 | $7,153 | $2,441 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 46 | $7,038 | $2,406 | 34.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 30 | 39 | $7,527 | $1,564 | 20.8% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 12 | 47 | $2,773 | $615.71 | 22.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 66 | 88 | $2,200 | $261.00 | 11.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 25 | $4,750 | $219.43 | 4.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 13 | $559.00 | $124.80 | 22.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 26 | 36 | $684.00 | $79.87 | 11.7% |
| J2350 | Injection, ocrelizumab, 1 mg | Office | 2021 | 25 | 16,501 | $1.2M | $307,025 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 93 | 139 | $31,796 | $10,221 | 32.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 55 | 89 | $17,177 | $3,630 | 21.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 63 | $9,639 | $3,358 | 34.8% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis | Office | 2021 | 42 | 134 | $7,906 | $1,666 | 21.1% |
About Christopher Hall, PA - C
Christopher Hall, PA - C is a Physician Assistant healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104023498.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Hall, PA - C has received a total of $6,608 in payments from pharmaceutical and medical device companies, with $1,647 received in 2024. These payments were reported across 421 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,608).
As a Medicare-enrolled provider, Hall has provided services to 1,245 Medicare beneficiaries, totaling 21,201 services with total Medicare billing of $429,606. Data is available for 3 years (2021–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical
- Location Augusta, GA
- Active Since 06/29/2007
- Last Updated 02/21/2014
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1104023498
Products in Payments
- UBRELVY (Drug) $500.38
- Ozempic (Drug) $402.46
- MOUNJARO (Drug) $380.24
- Rybelsus (Drug) $374.68
- VRAYLAR (Drug) $373.00
- FARXIGA (Drug) $327.48
- ELIQUIS (Drug) $312.35
- Kerendia (Drug) $276.96
- QULIPTA (Drug) $261.85
- REXULTI (Drug) $249.66
- NURTEC ODT (Drug) $236.68
- FREESTYLE LIBRE 3 (Device) $214.02
- Saxenda (Drug) $189.78
- Vascepa (Drug) $189.68
- TRELEGY ELLIPTA (Drug) $177.09
- JARDIANCE (Drug) $153.09
- AIRSUPRA (Drug) $144.75
- SOLIQUA 100/33 (Biological) $128.94
- MYRBETRIQ (Drug) $106.28
- XARELTO (Drug) $104.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Augusta
Jonell Poe, Pa, PA
Physician Assistant — Payments: $15,884
Physician Assistant $15,884
Kolyse Caver, Pa-C, PA-C
Physician Assistant — Payments: $13,032
Physician Assistant $13,032
Julie Buird, Pa, PA
Physician Assistant — Payments: $12,610
Physician Assistant $12,610
Lacey Preston, Pa-C, PA-C
Physician Assistant — Payments: $11,422
Physician Assistant $11,422
Clinton Rushing, Pa, PA
Physician Assistant — Payments: $9,175
Physician Assistant $9,175
Melania Velasquez, Pa, PA
Physician Assistant — Payments: $9,034
Physician Assistant $9,034